30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Posts Tagged ‘Sanofi SA (ADR) (SNY)’
Market Movers Today: Snap Inc (SNAP), Wynn Resorts, Limited (WYNN), Perry Ellis International, Inc. (PERY), and More
What happened: Shares of Snap (NYSE:SNAP) have skyrocketed today, up by 40% as of 12 p.m. EST, after the company reported strong fourth-quarter earnings.
Top 10 Generic Pharmaceutical Companies In 2017
The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries of economic cycles.
15 Best Selling Most Profitable Drugs of All Time
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Top 10 Largest Pharmaceutical Companies By Revenue in 2017
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (ADR) (SNY) Obtain Suspension of Injunction for Cholesterol Drug Sales
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen.
11 Largest Pharmaceutical Companies In The World
Did you know five of the 11 largest pharmaceutical companies in the world are US companies? The healthcare and pharmaceutical sector is one of the safest stock market sectors ...
Sanofi SA (ADR) (SNY) Hit With Cease And Desist Order On Dengue Vaccine Ads In The Philippines
The Philippines Food and Drug Administration has ordered Sanofi SA (ADR) (NYSE:SNY) to desist from advertising its dengue vaccine or face major consequences.
Mylan NV (MYL), AbbVie Inc (ABBV) Sanofi SA (ADR) (SNY) In Spotlight Over Price Hikes
A Vermont drug price transparency bill threatens to make it hard for drug makers to increase drug prices without explanations.
Regulator Demands Divestiture In Asset Swap Deal Between Boehringer, Sanofi SA (ADR) (SNY)
Boehringer Ingelheim, a German pharmaceutical firm, are involved in plans to divest of five kinds of products for animal health.
Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims
Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims.
EMA Reviews Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY) Dupixent MAA
The European Medicines Agency (EMA) has recently accepted to review the Marketing Authorization Application (MAA) of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (...
Sanofi SA (ADR) (SNY) Could Challenge Johnson & Johnson (JNJ) Bid For Actelion Ltd (ALIOF)
Sanofi SA (ADR) (NYSE:SNY) could spark a fierce bidding war for Actelion Ltd (OTCMKTS:ALIOF).
Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters
Manufacturing problems in France threaten to delay the release of Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s blockbuster drug, dupilumab, according...
US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6
The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...
Sanofi SA (ADR) (SNY) Can Thank Its Vaccines
Sanofi SA (ADR) (NYSE:SNY) Pasteur seems to be making it big with its vaccines. In the third quarter the French drugmaker’s sales grew by 14% over last year.
Hedge Fund Managers Discuss Shorting Viasat (VSAT), 2U (TWOU), Long Positions in Microsoft (MSFT), Others
Large hedge funds are required to disclose all of their long stakes in U.S.-traded securities once per quarter.
Why Investors Are Watching Dean Foods, Regeneron Pharmaceuticals, Halliburton, and More
It's another quiet day on the Street as the main indexes are moderately in the green while the VIX is down 3% to trade below 15.
Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...
FDA’s Sanofi SA (ADR) (SNY) Delay Highlights Some Red Flags With IGlarLixi
We just learnt that the FDA has pushed back its decision day on Sanofi SA (ADR) (NYSE:SNY)’s insulin combo candidate IGlarLixi.
Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?
It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve it.
The Most Popular French Stocks Among Hedge Funds
French president François Hollande was recently quoted as saying “ça va mieux” of his country's economy, which means that things are improving.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Why Traders Are Buzzing About MGM, Apple, and Three Other Companies Today
Although crude futures are well in the green, the three indexes have opened in the red on Friday. The Dow and S&P 500 are off by 0.2% while the NASDAQ index has lost around 0...
GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Warren Buffett’s Best High-Yield Dividend Stocks – May 2016 Update
Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...
Why These Five Stocks Are Trending Today?
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus 200,000 expected.
Why These Five Stocks Are on the Move Today?
Markets are trading lower on Friday following the recent sell-off in several tech stocks amid the earnings season.
Why Investors Are Buzzing About These Stocks Today
It's M&A Thursday, as several major M&A deals have been announced today.
Warren Buffett’s Best High-Yield Dividend Stocks
Warren Buffett’s Berkshire Hathaway outperformed the S&P 500 by 11.1% per year from 1965-2015, generating an overall gain of 1,598,284% compared to the market’s total return...
Here’s Why These 5 Stocks Are on the Move Today
With the NASDAQ index in the red and the S&P 500 and Dow Jones Indexes barely in the green, shares of Highpower International Inc (NASDAQ:HPJ), Chesapeake Energy Corporation (...
Billionaire Ken Fisher’s Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...
Why Are Investors Selling Shares of These Four Companies?
On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (NASDAQ:MNKD), Team Health Holdings...
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...
Ascendis Pharma A/S (ASND): Orbimed Advisors Takes Activist Stake in Newly Public Company
Samuel Isaly’s Orbimed Advisors has taken an activist stake in the recently listed Ascendis Pharma A/S (NASDAQ:ASND), an early-stage drug company working on a novel method of...
Regeneron Pharmaceuticals Inc (REGN) Calls Game, Set and Match On Its Competitor: Jim Cramer
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially those with a speculative...
InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since.
For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus
In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to...
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Sanofi SA (ADR) (SNY), Merck & Co., Inc. (MRK): Healthier Days Loom as 3 Big Pharmas Move on Dengue Shots
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
Billionaire Ken Fisher’s Healthcare Picks for Q3 Include Pfizer Inc. (PFE)
In mid July, Fisher Asset Management, the asset management firm run by billionaire and Forbes columnist Ken Fisher, filed its 13F for the second quarter of 2013 with the SEC, ...
Hedge Funds Are Betting On Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past.
Biogen Idec Inc. (BIIB) Bounces Higher
If you thought that the great run so far in 2013 was over for Biogen Idec Inc. (NASDAQ:BIIB), think again.
General Motors Company (GM), Sanofi SA (ADR) (SNY): Ex-Lehman Hedge Fund’s Favorite Equities
Managed by the former head of Global Trading Strategies for Lehman Brothers, Realm Partners was started in 2009 by Robert Millard with $650 million.
